PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Telmisartan with diuretic
Presentation Product Chemical substance Chapter Items dispensed
Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets
0205052R0AAABAB
Telmisartan/hydrochlorothiazide Telmisartan with diuretic Cardiovascular System 4,202
Telmisartan 40mg / Hydrochlorothiazide 12.5mg tablets
0205052R0AAAAAA
Telmisartan/hydrochlorothiazide Telmisartan with diuretic Cardiovascular System 2,724
Telmisartan 80mg / Hydrochlorothiazide 25mg tablets
0205052R0AAACAC
Telmisartan/hydrochlorothiazide Telmisartan with diuretic Cardiovascular System 1,008
MicardisPlus 80mg/12.5mg tablets
0205052R0BBABAB
MicardisPlus Telmisartan with diuretic Cardiovascular System 577
MicardisPlus 40mg/12.5mg tablets
0205052R0BBAAAA
MicardisPlus Telmisartan with diuretic Cardiovascular System 312
MicardisPlus 80mg/25mg tablets
0205052R0BBACAC
MicardisPlus Telmisartan with diuretic Cardiovascular System 163
Actelsar HCT 80mg/25mg tablets
0205052R0BCACAC
Actelsar Telmisartan with diuretic Cardiovascular System 5
Actelsar HCT 40mg/12.5mg tablets
0205052R0BCAAAA
Actelsar Telmisartan with diuretic Cardiovascular System No data available
Actelsar HCT 80mg/12.5mg tablets
0205052R0BCABAB
Actelsar Telmisartan with diuretic Cardiovascular System No data available
Tolucombi 40mg/12.5mg tablets
0205052R0BDAAAA
Tolucombi Telmisartan with diuretic Cardiovascular System No data available
Tolucombi 80mg/12.5mg tablets
0205052R0BDABAB
Tolucombi Telmisartan with diuretic Cardiovascular System No data available
Tolucombi 80mg/25mg tablets
0205052R0BDACAC
Tolucombi Telmisartan with diuretic Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.